ArticleJACC. Case reports2025
Multimodal Imaging Evaluation of Myocardial Involvement in Rare Oculoleptomeningeal Hereditary Transthyretin Amyloidosis.
Article in JACC. Case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIn hereditary (variant) transthyretin amyloidosis (vATTR), cardiomyopathy leads to worse outcomes. Of 140 identified TTR gene mutations, few are associated with oculoleptomeningeal amyloidosis. It remains unclear whether these mutations are linked to a cardiac phenotype. CASE SUMMARY: A 59-year-old man from Bosnia and Herzegovina initially presented with transient vision loss and was ultimately diagnosed with rare p.Ile127Met vATTR. We describe a detailed investigation of myocardial involvement harnessing multimodal cardiovascular imaging. DISCUSSION: No previous reports have specifically addressed the cardiac phenotype of oculoleptomeningeal amyloidosis. Our paper depicts a mild cardiac phenotype for the p.Ile127Met variant highlighting the need for awareness among cardiologists and emphasizing the necessity for close patient monitoring and expertise in evolving disease-modifying treatments. TAKE-HOME MESSAGES: Early diagnosis and risk stratification in patients with vATTR are challenging. Cardiologists need an increased awareness because they may encounter patients with seemingly rare vATTR, such as the p.Ile127Met variant discussed here.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.